merged_alzheimers-blood-test.txt
<question_number>1</question_number>
<answer>There are no therapies to offer for individuals without cognitive impairment who test positive for Alzheimer's disease pathology.</answer>

<question_number>2</question_number>
<answer>Primary care doctors were wrong 41% of the time when they thought patients did not have Alzheimer's, while the blood test was wrong only about 10% of the time.</answer>

<question_number>3</question_number>
<answer>Many people with subjective cognitive decline do not turn out to have Alzheimer's.</answer>

<question_number>4</question_number>
<answer>Blood test analysis needs to be easily integrated into hospital laboratory systems rather than requiring outside labs.</answer>

<question_number>5</question_number>
<answer>Ptau-217, a form of the protein tau.</answer>

<question_number>6</question_number>
<answer>In the context of research studies, not for general use in cognitively healthy individuals.</answer>

<question_number>7</question_number>
<answer>Kidney disease.</answer>

<question_number>8</question_number>
<answer>Risk of anxiety and other psychological reactions to test results predicting future Alzheimer's development.</answer>

<question_number>9</question_number>
<answer>41%.</answer>

<question_number>10</question_number>
<answer>If primary care doctors can eventually use these tests, it will increase access to screening, especially for people from racial and ethnic minorities and low-income and rural communities.</answer>